Thus, hsa_circ_0001162 has been reported to promote DN podocyte injury by regulating MMP9 expression through a ceRNA mechanism, which lays the groundwork for the molecular diagnosis and targeted therapy of DN. The gene discussed is MMP9; the disease is liver dysplastic nodule.